Monsanto Company Profile (NYSE:MON)

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity. Through its Seeds and Genomics segment, the Company produces seed brands, including DEKALB, Asgrow, Deltapine, Seminis and De Ruiter, and it develops biotechnology traits that assist farmers in controlling insects and weeds and precision agriculture to assist farmers in decision-making. It offers products, such as Germplasm and Biotechnology traits. Through its Agricultural Productivity segment, the Company manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Industry, Sector and Symbol:

Sector: Basic Materials
Industry: Agricultural Chemicals
Sub-Industry: Fertilizers & Agricultural Chemicals
Exchange: NYSE
Symbol: MON
CUSIP: 61166W10

Key Metrics:

Previous Close: $103.50
50 Day Moving Average: $105.73
200 Day Moving Average: $100.56
52-Week Range: $82.81 - $114.26
Trailing P/E Ratio: 45.55
Foreward P/E Ratio: 21.12
P/E Growth: 3.47
Market Cap: $45.29B
Outstanding Shares: 437,575,000
Beta: 1.24

Profitability:

Net Margins: 7.76%
Return on Equity: 37.98%
Return on Assets: 9.07%

Debt:

Debt-to-Equity Ratio: 1.55%
Current Ratio: 1.47%
Quick Ratio: 0.92%

Additional Links:

Companies Related to Monsanto:

Consensus Ratings for Monsanto (NYSE:MON) (?)

Ratings Breakdown:	4 Sell Ratings, 5 Hold Ratings, 15 Buy Ratings
Consensus Rating:	Hold (Score: 2.46)
Consensus Price Target:	$112.55 (8.74% upside)

Analysts' Ratings History for Monsanto (NYSE:MON)

Show:

Date	Firm	Action	Rating	Price Target
9/21/2016	JPMorgan Chase & Co.	Upgrade	Neutral -> Overweight	$128.00
9/15/2016	Piper Jaffray Cos.	Set Price Target	Buy	$128.00
9/15/2016	Sanford C. Bernstein	Reiterated Rating	Sell
9/15/2016	BMO Capital Markets	Set Price Target	Buy	$128.00
9/15/2016	S&P Equity Research	Reiterated Rating	Positive
9/15/2016	Deutsche Bank AG	Boost Price Target	Buy	$118.00 -> $128.00
9/15/2016	Credit Agricole SA	Downgrade	Buy -> Underperform	$110.00
9/6/2016	Jefferies Group	Reiterated Rating	Buy
8/19/2016	Citigroup Inc.	Boost Price Target	Neutral	$112.00 -> $116.00
8/8/2016	Monness Crespi & Hardt	Upgrade	Neutral -> Buy	$106.93 -> $130.00
6/27/2016	Goldman Sachs Group Inc.	Set Price Target	Sell	$92.00
6/15/2016	Argus	Reiterated Rating	Buy	$111.00 -> $128.00
5/27/2016	Atlantic Securities	Downgrade	Overweight -> Neutral	$109.62 -> $105.00
5/25/2016	Macquarie	Set Price Target	Buy	$110.00
5/24/2016	Wells Fargo & Co.	Reiterated Rating	Hold
5/23/2016	Vertical Research	Upgrade	Hold -> Buy
5/13/2016	Berenberg Bank	Set Price Target	Buy	$110.00
4/12/2016	Susquehanna	Lower Price Target	Positive	$105.00 -> $101.00
4/9/2016	Morgan Stanley	Reiterated Rating	Buy
4/7/2016	Bank of America Corp.	Reiterated Rating	Sell	$88.00
3/3/2016	Vertical Group	Downgrade	Buy -> Hold
3/3/2016	Barclays PLC	Lower Price Target	Equal Weight	$100.00 -> $95.00
3/2/2016	Credit Suisse Group AG	Lower Price Target	Outperform	$109.00 -> $97.00
10/9/2015	Stifel Nicolaus	Lower Price Target	Buy	$135.00 -> $115.00
8/24/2015	Canaccord Genuity	Reiterated Rating	Buy	$134.00 -> $126.00
5/6/2015	BB&T Corp.	Initiated Coverage	Hold -> Hold
1/20/2015	Topeka Capital Markets	Reiterated Rating	Hold	$111.00
1/2/2015	Miller Tabak	Downgrade	Buy -> Neutral

(Data available from 9/25/2014 forward)

Earnings History for Monsanto (NYSE:MON)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/5/2016
6/29/2016	Q316	$2.40	$2.17	$4.49 billion	$4.19 billion	View	Listen
4/6/2016	Q216	$2.44	$2.42	$4.81 billion	$4.53 billion	View	N/A
1/6/2016	Q116	($0.22)	($0.11)	$2.41 billion	$2.22 billion	View	Listen
10/7/2015	Q415	($0.02)	($0.19)	$2.79 billion	$2.36 billion	View	Listen
6/24/2015	Q315	$2.06	$2.39		$4.58 billion	View	Listen
4/1/2015	Q215	$2.93	$2.90	$5.58 billion	$5.20 billion	View	Listen
1/7/2015	Q115	$0.35	$0.47	$2.80 billion	$2.87 billion	View	Listen
10/8/2014	Q414	($0.23)	($0.27)	$2.41 billion	$2.63 billion	View	Listen
6/25/2014	Q314	$1.56	$1.62	$4.41 billion	$4.25 billion	View	Listen
4/2/2014	Q214	$3.08	$3.15	$5.81 billion	$5.83 billion	View	Listen
1/8/2014	Q1	$0.64	$0.67	$3.08 billion	$3.15 billion	View	Listen
10/2/2013	Q413	($0.43)	($0.47)	$2.24 billion	$2.20 billion	View	Listen
6/26/2013	Q3 2013	$1.59	$1.66	$4.41 billion	$4.25 billion	View	Listen
4/3/2013	Q2 2013	$2.58	$2.73	$5.29 billion	$5.47 billion	View	N/A
1/8/2013	Q1 2013	$0.37	$0.62	$2.64 billion	$2.93 billion	View	Listen
10/3/2012	Q412	($0.43)	($0.44)	$2.25 billion	$2.11 billion	View	N/A
6/27/2012		$1.58	$1.63			View	N/A
4/4/2012		$2.11	$2.28			View	N/A
1/5/2012		$0.17	$0.23			View	N/A
10/5/2011		($0.27)	($0.22)			View	N/A
4/6/2011		$1.84	$1.87			View	N/A
1/6/2011		$0.01	$0.02			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Monsanto (NYSE:MON)

Current Year EPS Consensus Estimate: $4.44 EPS
Next Year EPS Consensus Estimate: $4.9 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	5	$2.35	$2.99	$2.66
Q2 2016	3	$2.29	$2.73	$2.50
Q3 2016	4	($0.18)	$0.15	($0.02)
Q4 2016	2	($0.08)	$0.39	$0.16
Q1 2017	1	$3.57	$3.57	$3.57
Q2 2017	1	$2.57	$2.57	$2.57

(Data provided by Zacks Investment Research)

Current Dividend Information for Monsanto (NYSE:MON)

Annual Dividend:	$2.16
Dividend Yield:	2.09%
Dividend Growth:	16.40% (3 Year Average)
Payout Ratio:	89.26% (Based on Trailing 12 Months of Earnings) 48.65% (Based on Current Year Consensus EPS Estimate) 44.08% (Based on Next Year Consensus EPS Estimate)
Track Record:	6 Years of Consecutive Dividend Growth

Dividend History for Monsanto (NYSE:MON)

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/12/2016	quarterly	$0.54	2.06%	10/5/2016	10/7/2016	10/28/2016
6/9/2016	quarterly	$0.54	1.98%	7/6/2016	7/8/2016	7/29/2016
1/29/2016	quarterly	$0.54	2.4%	4/6/2016	4/8/2016	4/29/2016
12/7/2015	quarterly	$0.54	2.23%	1/6/2016	1/8/2016	1/29/2016
8/4/2015	quarterly	$0.54	2.1%	10/7/2015	10/9/2015	10/30/2015
6/8/2015	quarterly	$0.49	1.72%	6/30/2015	7/2/2015	7/24/2015
2/2/2015	quarterly	$0.49	1.65%	3/31/2015	4/2/2015	4/24/2015
12/8/2014	quarterly	$0.49	1.63%	1/7/2015	1/9/2015	1/30/2015
8/5/2014	quarterly	$0.49	1.69%	10/8/2014	10/10/2014	10/31/2014
6/6/2014	quarterly	$0.43	1.42%	7/1/2014	7/3/2014	7/25/2014
1/28/2014	quarterly	$0.43	1.61%	4/2/2014	4/4/2014	4/25/2014
12/9/2013	quarterly	$0.43	1.54%	1/8/2014	1/10/2014	1/31/2014
8/6/2013	quarterly	$0.43	1.81%	10/2/2013	10/4/2013	10/25/2013
6/6/2013	quarterly	$0.38	1.48%	7/2/2013	7/5/2013	7/26/2013
1/31/2013	quarterly	$0.38	1.47%	4/3/2013	4/5/2013	4/26/2013

(Data available from 1/1/2013 forward)

Insider Trading History for Monsanto (NYSE:MON)

Insider Ownership Percentage: 0.88%
Institutional Ownership Percentage: 79.06%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
7/14/2016	Brett D Begemann	COO	Sell	27,980	$103.62	$2,899,287.60
7/13/2016	Michael K Stern	CEO	Sell	12,797	$101.77	$1,302,350.69
4/19/2016	George Poste	Director	Sell	1,136	$91.93	$104,432.48
4/14/2016	Steven Mizell	EVP	Sell	9,500	$89.06	$846,070.00
4/12/2016	Charles S Mcmillan	Director	Buy	3,500	$87.25	$305,375.00
4/12/2016	Michael J Frank	VP	Sell	2,000	$87.49	$174,980.00
4/11/2016	Steven Mizell	EVP	Sell	3,900	$86.87	$338,793.00
11/17/2015	Kerry J. Preete	EVP	Sell	4,667	$95.62	$446,258.54
10/21/2015	William U Parfet	Director	Sell	17,000	$91.16	$1,549,720.00
10/13/2015	Steven Mizell	VP	Sell	6,100	$89.40	$545,340.00
4/15/2015	Kerry J Preete	EVP	Sell	27,580	$119.37	$3,292,224.60
4/8/2015	Tom D Hartley	VP	Sell	4,600	$117.91	$542,386.00
2/13/2015	Michael K Stern	COO	Sell	1,391	$125.00	$173,875.00
1/20/2015	David F Snively	EVP	Sell	29,521	$117.14	$3,458,089.94
1/12/2015	Steven Mizell	VP	Sell	20,500	$118.72	$2,433,760.00
11/17/2014	Nicole M Ringenberg	VP	Sell	12,780	$118.83	$1,518,647.40
10/15/2014	Robert T Fraley	EVP	Sell	10,679	$107.93	$1,152,584.47
10/14/2014	Nicole M Ringenberg	VP	Sell	2,500	$108.01	$270,025.00
10/13/2014	Steven Mizell	VP	Sell	3,480	$106.08	$369,158.40
9/3/2014	Kerry J Preete	EVP	Sell	3,827	$115.50	$442,018.50
7/8/2014	Michael J Frank	VP	Sell	7,500	$124.53	$933,975.00
7/7/2014	Robert T Fraley	EVP	Sell	54,740	$125.32	$6,860,016.80
7/3/2014	David F Snively	EVP	Sell	35,220	$126.25	$4,446,525.00
7/3/2014	William U Parfet	Director	Sell	23,800	$126.52	$3,011,176.00
5/23/2014	Janet M Holloway	SVP	Sell	21,280	$120.00	$2,553,600.00
5/7/2014	Kerry Preete	EVP	Sell	49,850	$115.00	$5,732,750.00
4/15/2014	Hugh Grant	CEO	Sell	95,000	$110.33	$10,481,350.00
4/15/2014	Tom Hartley	VP	Sell	7,900	$110.51	$873,029.00
1/17/2014	Hugh Grant	CEO	Sell	44,179	$112.69	$4,978,531.51
1/16/2014	Robert Fraley	EVP	Sell	64,850	$112.57	$7,300,164.50
1/14/2014	Steven Mizell	VP	Sell	24,000	$112.05	$2,689,200.00
11/11/2013	Nicole Ringenberg	VP	Sell	13,560	$107.04	$1,451,462.40
10/15/2013	Tom Hartley	VP	Sell	5,860	$105.70	$619,402.00
10/8/2013	Steven Mizell	VP	Sell	11,370	$104.50	$1,188,165.00
10/7/2013	Nicole Ringenberg	VP	Sell	3,500	$105.02	$367,570.00
9/4/2013	Kerry Preete	EVP	Sell	5,276	$99.00	$522,324.00
7/19/2013	Gerald A Steiner	EVP	Sell	12,293	$104.00	$1,278,472.00
7/9/2013	Tom D Hartley	VP	Sell	6,000	$100.15	$600,900.00
7/8/2013	Janet M Holloway	SVP	Sell	10,700	$98.80	$1,057,160.00
7/3/2013	Hugh Grant	CEO	Sell	40,000	$97.74	$3,909,600.00
7/2/2013	Steven Mizell	VP	Sell	37,000	$97.71	$3,615,270.00
5/13/2013	David F Snively	EVP	Sell	106,366	$107.24	$11,406,689.84
5/1/2013	Pierre Courduroux	CFO	Sell	5,720	$105.47	$603,288.40

(Data available from 1/1/2013 forward)

Latest Headlines for Monsanto (NYSE:MON)

Date	Headline
	Monsanto Outsmarts the GMO Resistance (NYSE:MON) tapnewswire.com - September 24 at 5:42 PM
	Monsanto Agrees to Use Gene-Editing Tool CRISPR Responsibly (NYSE:MON) motherboard.vice.com - September 24 at 5:42 PM
	Opposed to GMOs? What about Monsanto’s new CRISPR crops? (NYSE:MON) www.digitaltrends.com - September 24 at 5:42 PM
	Monsanto Strikes DNA-Editing Deal With Broad Institute, Harvard (NYSE:MON) www.agweb.com - September 24 at 10:39 AM
	Monsanto cuts deal to use CRISPR to engineer food (NYSE:MON) www.newscientist.com - September 24 at 10:39 AM
	Food Blackmail: The Potential Danger of Bayer’s Purchase of Monsanto (NYSE:MON) www.thedailybeast.com - September 24 at 10:39 AM
	Monsanto : Secures Tech License from Broad Institute (NYSE:MON) www.4-traders.com - September 24 at 10:39 AM
	Monsanto signs license deal for gene-editing technology (NYSE:MON) www.bizjournals.com - September 24 at 10:39 AM
	Monsanto Just Got Access to the World’s Most Powerful Gene-Editing Tool (NYSE:MON) gizmodo.com - September 24 at 10:38 AM
	Monsanto Strikes DNA-Editing Deal With Broad Institute, Harvard - AgWeb (NYSE:MON) www.agweb.com - September 23 at 5:49 PM
	Monsanto-Bayer Merger: Here's Why Investors Are Skeptical (NYSE:MON) www.fool.com - September 23 at 1:27 PM
	Why is the U.S. government so keen to protect Monsanto? (NYSE:MON) www.naturalnews.com - September 23 at 10:52 AM
	Monsanto Licenses Broad Institute CRISPR/Cas9 Technology (NYSE:MON) www.genengnews.com - September 23 at 10:52 AM
	Combined company will honor Monsanto's local commitments (NYSE:MON) www.stltoday.com - September 23 at 10:52 AM
	Big Pharma – Big Agra Mergers: Furthering the Synthetic Agenda (NYSE:MON) cultureofawareness.com - September 23 at 10:52 AM
	Monsanto Has No Power Here: EU's Food Safety Commissioner (NYSE:MON) www.foxbusiness.com - September 23 at 10:52 AM
	'A Five-Alarm Threat to Our Food Supply': Experts Describe Bayer-Monsanto Merger (NYSE:MON) www.alternet.org - September 23 at 10:52 AM
	Monsanto To Use CRISPR Gene Editing Tech To Create New Seeds (NYSE:MON) www.vocativ.com - September 23 at 10:52 AM
	Bayer-Monsanto deal pilloried by skeptical German lawmakers (NYSE:MON) farmfutures.com - September 23 at 10:52 AM
	Sold-out Farm Tank Summit raises frank discussion about agriculture, technology (NYSE:MON) www.bizjournals.com - September 23 at 10:52 AM
	Monsanto Co. (NYSE: MON) Upgraded at JPMorgan Chase & Co. - The Ledger Gazette (NYSE:MON) ledgergazette.com - September 22 at 5:54 PM
	12:01 pm Monsanto reaches a global licensing agreement for the use of the CRISPR-Cas genome-editing technology in agriculture with the Broad Institute of MIT and Harvard (NYSE:MON) finance.yahoo.com - September 22 at 5:54 PM
	Monsanto Announces Global Licensing Agreement with Broad Institute on Key Genome-Editing Application (NYSE:MON) www.publicnow.com - September 22 at 5:54 PM
	Monsanto may have just ended the war on GMOs (NYSE:MON) finance.yahoo.com - September 22 at 5:54 PM
	[$$] Li Ka-shing means more ka-ching for Grid (NYSE:MON) www.ft.com - September 22 at 5:54 PM
	Altria Announces Consummation of Cash Tender Offer and Final Results (NYSE:MON) www.publicnow.com - September 22 at 5:54 PM
	Bayer-Monsanto Merger Plan Draws US Senate Scrutiny - Voice of America (NYSE:MON) www.voanews.com - September 22 at 10:59 AM
	Bayer's Diligence Failure In Merck Deal Haunts Its Monsanto Purchase - Wall Street Journal (blog) (NYSE:MON) blogs.wsj.com - September 21 at 5:52 PM
	Bayer-Monsanto Mega Deal Pilloried by Skeptical German Lawmakers - Bloomberg (NYSE:MON) www.bloomberg.com - September 21 at 5:52 PM
	BRIEF-Monsanto Co - Bayer not required to take any material adverse divest... - Reuters (NYSE:MON) www.reuters.com - September 21 at 5:52 PM
	BRIEF-Monsanto Co - Bayer is committed to make divestitures to obtain anti... - Reuters (NYSE:MON) www.reuters.com - September 21 at 5:52 PM
	Bayer Might Drop Monsanto's Toxic Name (NYSE:MON) www.investopedia.com - September 21 at 5:52 PM
	Bayer-Monsanto tie-up pilloried in Germany, U.S. (NYSE:MON) seekingalpha.com - September 21 at 3:53 PM
	Monsanto upgraded at J.P. Morgan (NYSE:MON) seekingalpha.com - September 21 at 3:53 PM
	Monsanto Upgraded Ahead of Buyout: 3 Things You Need to Know (NYSE:MON) www.fool.com - September 21 at 1:30 PM
	Monsanto, Bayer officials defend proposed $66 billion merger (NYSE:MON) www.msn.com - September 21 at 10:20 AM
	Will Monsanto Now Try To Hide? (NYSE:MON) healthimpactnews.com - September 21 at 10:20 AM
	Bayer Considers Letting Go of the Monsanto Name (NYSE:MON) fortune.com - September 21 at 10:20 AM
	Bayer outlines €10B new-drug sales target to allay post-Monsanto worries (NYSE:MON) www.fiercepharma.com - September 21 at 10:20 AM
	Monsanto, Bayer execs insist merger a benefit (NYSE:MON) www.nwaonline.com - September 21 at 10:20 AM
	Bayer Boss, Bullish on Growth, Defends Monsanto Deal (NYSE:MON) www.wsj.com - September 21 at 10:20 AM
	Monsanto, Bayer Officials Defend Proposed Merger (NYSE:MON) www.usatoday.com - September 21 at 10:20 AM
	Monsanto (MON) Stock Higher, Upgraded at JPMorgan (NYSE:MON) www.thestreet.com - September 21 at 10:19 AM
	Analysts' Actions -- Clovis, Altria, Sketchers, Wells Fargo and More (NYSE:MON) finance.yahoo.com - September 21 at 10:19 AM
	Neo Technology and Monsanto to Co-Present at Strata + Hadoop World 2016 in New York (NYSE:MON) finance.yahoo.com - September 21 at 10:19 AM
	BRIEF-Monsanto Co - Bayer is committed to make divestitures to obtain antitrust approvals (NYSE:MON) feeds.reuters.com - September 21 at 8:45 AM
	BRIEF-Monsanto Co - Bayer not required to take any material adverse divestiture action (NYSE:MON) feeds.reuters.com - September 20 at 6:40 PM
	BRIEF-Monsanto says bayer not required to take any divestiture action (NYSE:MON) feeds.reuters.com - September 20 at 6:40 PM
	Bayer, Monsanto to Create a Global Leader in Agriculture (NYSE:MON) www.diversityinc.com - September 20 at 11:24 AM
	Bayer-Monsanto deal making farmers uneasy (NYSE:MON) www.660news.com - September 20 at 11:24 AM